Markets › United States › NAS › ATTO

Attovia Therapeutics Inc

NAS:ATTOHealth Technologynasdaq_composite

$13.89+1.17%At closeAt close · Tue 20 Oct · ≈ AED 51.01 · Market cap $634.1M · Next earnings Wed 2 Dec

USD millions	FY2024	FY2025
Revenue	0.0	1.4
Cost of revenue	0.3	0.8
Gross profit	(0.3)	0.5
Research & development	33.9	54.2
Operating expenses	41.2	67.7
Operating income	(41.6)	(67.2)
Interest expense	0.0	0.0
Interest income	3.4	6.6
Pre-tax income	(39.8)	(60.6)
Income tax	0.0	0.0
Net income	(45.0)	(60.9)
EPS, basic (per share)	(0.99)	(1.33)
EPS, diluted (per share)	(0.99)	(1.33)
EBITDA	(41.2)	(66.4)
Depreciation & amortization	0.3	0.8
Weighted average shares (shares)	45,651,262	45,651,262
Weighted average diluted shares (shares)	45,651,262	45,651,262
Gross margin	—	40.4%
Operating margin	—	−4,974.7%
Net margin	—	−4,511.0%